rs1333494917
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6BP7
The NM_001387283.1(SMARCA4):c.3792G>A(p.Thr1264Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000478 in 627,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001387283.1 synonymous
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMARCA4 | NM_001387283.1 | c.3792G>A | p.Thr1264Thr | synonymous_variant | Exon 27 of 36 | ENST00000646693.2 | NP_001374212.1 | |
| SMARCA4 | NM_003072.5 | c.3792G>A | p.Thr1264Thr | synonymous_variant | Exon 27 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.3792G>A | p.Thr1264Thr | synonymous_variant | Exon 27 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
| SMARCA4 | ENST00000344626.10 | c.3792G>A | p.Thr1264Thr | synonymous_variant | Exon 27 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
| SMARCA4 | ENST00000643995.1 | c.3204G>A | p.Thr1068Thr | synonymous_variant | Exon 24 of 32 | ENSP00000496004.1 | ||||
| SMARCA4 | ENST00000644963.1 | c.2436G>A | p.Thr812Thr | synonymous_variant | Exon 20 of 28 | ENSP00000495599.1 | ||||
| SMARCA4 | ENST00000642350.1 | c.2277G>A | p.Thr759Thr | synonymous_variant | Exon 19 of 27 | ENSP00000495355.1 | ||||
| SMARCA4 | ENST00000643857.1 | c.2145G>A | p.Thr715Thr | synonymous_variant | Exon 18 of 25 | ENSP00000494159.1 | ||||
| SMARCA4 | ENST00000643549.1 | c.3774+267G>A | intron_variant | Intron 26 of 34 | ENSP00000493975.1 | |||||
| SMARCA4 | ENST00000541122.6 | c.3774+267G>A | intron_variant | Intron 27 of 34 | 5 | ENSP00000445036.2 | ||||
| SMARCA4 | ENST00000643296.1 | c.3774+267G>A | intron_variant | Intron 26 of 33 | ENSP00000496635.1 | |||||
| SMARCA4 | ENST00000644737.1 | c.3774+267G>A | intron_variant | Intron 26 of 33 | ENSP00000495548.1 | |||||
| SMARCA4 | ENST00000589677.5 | c.3774+267G>A | intron_variant | Intron 27 of 34 | 5 | ENSP00000464778.1 | ||||
| SMARCA4 | ENST00000644065.1 | c.2499+267G>A | intron_variant | Intron 19 of 26 | ENSP00000493615.1 | |||||
| SMARCA4 | ENST00000538456.4 | c.30+267G>A | intron_variant | Intron 1 of 7 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000406 AC: 1AN: 246006 AF XY: 0.00000745 show subpopulations
GnomAD4 exome AF: 0.00000478 AC: 3AN: 627700Hom.: 0 Cov.: 2 AF XY: 0.00000585 AC XY: 2AN XY: 341988 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1
In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge -
Rhabdoid tumor predisposition syndrome 2 Benign:1
- -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at